Megan Munsie, PhD |
[1] Petersen A, Munsie M, Tanner C, MacGregor C & Brophy J (2017) Stem Cell Tourism and the Political Economy of Hope. Basingstoke: Palgrave Macmillan. doi: 10.1057/978-1-137-47043-0 [2] Munsie M, Lysaght T, Hendl T, Tan HL, Kerridge I and Stewart C (2017) Open for business: a comparative study of websites selling autologous stem cells in Australia and Japan. Regenerative Medicine 12(7). doi: 10.2217/rme-2017-0070 [3] Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A and Rasko JEJ (2017) Marketing of unproven stem cell-based interventions: A call to action. Sci Transl Med. 9(397). pii: eaag0426. doi: 10.1126/scitranslmed.aag0426. [4] Munsie M and Hyun I (2014) A question of ethics: Selling autologous stem cell therapies flaunts professional standards. Stem Cell Research. 13(3 Pt B): 647-53. doi: 10.1016/j.scr.2014.04.014. [5] Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermerén G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ. (2008) New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 3: 607-9. doi: 10.1016/j.stem.2008.11.009. |